Afrin
- Product NDC
- 67751-185
- 11-digit product format
- 677510185
- Labeler code
- 67751
- Product ID
- 67751-185_2385f57c-492c-9e37-e063-6394a90ad69d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- OXYMETAZOLINE HYDROCHLORIDE
- Dosage form
- SPRAY
- Route
- TOPICAL
- Labeler
- Navajo Manufacturing Company Inc.
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2017-12-04
- Substance
- OXYMETAZOLINE HYDROCHLORIDE
- Active strength
- .05 g/100mL
- Pharmacologic classes
- Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Afrin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OXYMETAZOLINE HYDROCHLORIDE | .05 g/100mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| K89MJ0S5VY | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 65bf1556-f234-9439-e053-2a91aa0a3194 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 726062af-1135-4707-a1d7-57256991bbf9 | Product name | 2 | 20250226 |
| e67be450-f8e4-4bc1-88bd-1259d379f55f | Product name | 1 | 20210127 |
| c53f3286-4062-4cf5-8355-399519c639a6 | Product name | 1 | 20170424 |
| a993dfc5-f219-4460-bde6-30dd724d9ef0 | Product name | 1 | 20160818 |
| 19c71a3d-ed9c-166b-a7e5-38c250c35631 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67751-185-01 | 2023-03-15 | C162847 | 48780-1 | f386c649-ebc6-0266-e053-dadaa90a7c1a | Afrin |
| 67751-185-01 | 2023-01-30 | C162847 | 48780-1 | f386c649-ebc6-0266-e053-dadaa90a7c1a | Afrin |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67751-185-01 | Afrin | 15 mL in 1 BOTTLE, SPRAY | SPRAY | 15 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Exchange Select Nasal | OXYMETAZOLINE HCL | Army & Air Force Exchange Service | 40d2090d-c332-4dcb-9f43-5ee467e7b3d1 | 2024-08-27 | Warnings | M012 |
| Signature Care Nasal Decongestant | OXYMETAZOLINE HCL | Safeway | 23f0a5b3-59ae-4eb3-9b7d-e6a492060337 | 2024-08-27 | Warnings | M012 |
| DG Health Nasal | OXYMETAZOLINE HYDROCHLORIDE | Dolgencorp, LLC | debcda99-c605-4941-b873-9e4dbae27483 | 2024-08-27 | Warnings | M012 |
| Good Neighbor Pharmacy Nasal | OXYMETAZOLINE HCL | Amerisource Bergen | d374d697-2b57-4558-a20b-d3d89aea82d7 | 2024-08-27 | Warnings | M012 |
| nasal | OXYMETAZOLINE HCL | Meijer Distribution Inc | 3984cbc3-b60c-40a7-bc3a-7d1f600503ac | 2024-08-27 | Warnings | M012 |
| foster and thrive nasal | OXYMETAZOLINE HYDROCHLORIDE | Strategic Sourcing Services LLC | e6e51821-03ae-4ec3-82a9-b4a8feacd996 | 2024-08-27 | Warnings | M012 |
| Pyrilamine Maleate and Dextromethorphan Hydrobromide | PYRILAMINE MALEATE AND DEXTROMETHORPHAN HYDROBROMIDE | Westminster Pharmaceuticals, LLC | dd068449-9d24-41e6-8a6e-f69c9fe263f2 | 2024-08-26 | Warnings | M012 |
| basic care nasal | OXYMETAZOLINE HYDROCHLORIDE | Amazon.com Services LLC | a154e500-2b45-4242-a26c-9530849f99df | 2024-08-23 | Warnings | M012 |
| Daytime Nighttime Ultra Concentrated Cold and Flu | DAYTIME - ACETAMINOPHEN, DEXTROMETHROPHAN HBR, PHENYLEPHRINE HCL AND NIGHTTIME - ACETAMINOPHEN, DEXTROMETHROPHAN HBR, DOXYLAMINE SUCCINATE | TARGET CORPORATION | 0c0cf76f-2dd3-45ef-e063-6394a90a9fef | 2024-08-22 | Warnings | M012 |
| Day Cold and Flu and Night Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, TRIPROLIDINE HCL | TARGET CORPORATION | 08ee56d1-b11d-3e36-e063-6294a90acd5f | 2024-08-22 | Warnings | M012 |
| Maximum Strength Daytime Cold and Flu and Nighttime Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, AND ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE,TRIPROLIDINE HYDROCHLORIDE | TARGET CORPORATION | 0fc523ce-55a7-6384-e063-6394a90aad3f | 2024-08-22 | Warnings | M012 |
| Cold and Flu Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Walgreens | 8045aef9-22bc-4146-b494-dbb1ffef06df | 2024-08-19 | Warnings | M012 |
| Allergy Relief | DIPHENHYDRAMINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 5a2053d4-9c0d-4613-9cf5-0067173f3730 | 2024-08-16 | Warnings | M012 |
| QUALITY CHOICE Long Acting Cough Softgel | DEXTROMETHORPHAN HYDROBROMIDE | Chain Drug Marketing Association, Inc. | f1ea7dfc-c605-45a1-ad1d-6e636a8a7b1c | 2024-08-16 | Warnings | M012 |
| pseudoephedrine hydrochloride | PSEUDOEPHEDRINE HCL | Padagis Israel Pharmaceuticals Ltd | 458594e1-8d99-4de3-8923-2fd8ce2fc406 | 2024-08-16 | Warnings | M012 |
| Halls Sugar Free Mountain Menthol | MENTHOL | Mondelez Global LLC | 54e0d57e-1f48-45e2-86b3-0e50775996f4 | 2024-08-15 | Warnings | M012 |
| SanaTos X Children | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCI | Pharmadel LLC | 1fc1408c-c540-39ab-e063-6394a90aa477 | 2024-08-15 | Warnings | M012 |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | NuCare Pharmaceuticals, Inc. | 489645ad-d7da-5f52-e054-00144ff8d46c | 2024-08-14 | Warnings | M012 |
| nasal | OXYMETAZOLINE HYDROCHLORIDE | Rite Aid Corporation | 6c949602-e0c8-40ce-8fb3-5147f406fa04 | 2024-08-14 | Warnings | M012 |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | NuCare Pharmaceuticals, Inc. | 3dbdf020-ca17-1197-e054-00144ff8d46c | 2024-08-13 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1000992 | Afrin 0.05 % Nasal Spray | PSN | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
| 1000990 | oxymetazoline HCl 0.05 % Nasal Spray | PSN | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
| 1000992 | oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray [Afrin] | SBD | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
| 1000990 | oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray | SCD | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
| 1000992 | Afrin 0.05 % Nasal Spray | SY | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
| 1000992 | Afrin 0.5 MG/ML Nasal Spray | SY | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
| 1000990 | oxymetazoline hydrochloride 0.05 % Nasal Spray | SY | 65bf1556-f234-9439-e053-2a91aa0a3194 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67751-185-01 | 67751018501 | 15 mL in 1 BOTTLE, SPRAY (67751-185-01) | 15 ml | 2017-12-04 | 0000-00-00 | No | No | Current |